Hydrogen sulfide mitigates homocysteine-mediated pathological remodeling by inducing miR-133a in cardiomyocytes

Molecular and Cellular Biochemistry
Varun KesherwaniParas K Mishra

Abstract

An elevated level of homocysteine called hyperhomocysteinemia (HHcy) is associated with pathological cardiac remodeling. Hydrogen sulfide (H2S) acts as a cardioprotective gas; however, the mechanism by which H2S mitigates homocysteine-mediated pathological remodeling in cardiomyocytes is unclear. We hypothesized that H2S ameliorates HHcy-mediated hypertrophy by inducing cardioprotective miR-133a in cardiomyocytes. To test the hypothesis, HL1 cardiomyocytes were treated with (1) plain medium (control, CT), (2) 100 µM of homocysteine (Hcy), (3) Hcy with 30 µM of H2S (Hcy + H2S), and (4) H2S for 24 h. The levels of hypertrophy markers: c-fos, atrial natriuretic peptide (ANP), and beta-myosin heavy chain (β-MHC), miR-133a, and its transcriptional inducer myosin enhancer factor-2C (MEF2C) were determined by Western blotting, RT-qPCR, and immunofluorescence. The activity of MEF2C was assessed by co-immunoprecipitation of MEF2C with histone deacetylase-1(HDAC1). Our results show that H2S ameliorates homocysteine-mediated up-regulation of c-fos, ANP, and β-MHC, and down-regulation of MEF2C and miR-133a. HHcy induces the binding of MEF2C with HDAC1, whereas H2S releases MEF2C from MEF2C-HDAC1 complex causing activation of MEF2C. These f...Continue Reading

References

Apr 1, 1996·Nature Medicine·K S McCully
Jul 24, 1997·The New England Journal of Medicine·O NygårdS E Vollset
Apr 30, 1998·Circulation Research·K L VikstromL A Leinwand
Aug 2, 2000·The American Journal of Clinical Nutrition·L Brattström, D E Wilcken
Jan 9, 2001·Arteriosclerosis, Thrombosis, and Vascular Biology·A JagerC D Stehouwer
Mar 15, 2006·The New England Journal of Medicine·Eva LonnUNKNOWN Heart Outcomes Prevention Evaluation (HOPE) 2 Investigators
Mar 15, 2006·The New England Journal of Medicine·Kaare Harald BønaaUNKNOWN NORVIT Trial Investigators
Jun 6, 2006·Revista española de cardiología·Juan Eduardo CarreñoJorge E Jalil
May 1, 2007·Nature Medicine·Alessandra CarèGianluigi Condorelli
Jul 17, 2007·Cardiovascular Research·Wen-Jie CaiYi-Chun Zhu
Sep 20, 2007·Proceedings of the National Academy of Sciences of the United States of America·John W ElrodDavid J Lefer
Dec 21, 2007·Proceedings of the National Academy of Sciences of the United States of America·Ning LiuEric N Olson
Aug 30, 2008·Annual Review of Medicine·Bradley A Maron, Joseph Loscalzo
Jan 20, 2009·Recent Patents on Cardiovascular Drug Discovery·Enrico VizzardiLivio Dei Cas
Jul 18, 2009·Circulation Research·John W CalvertDavid J Lefer
Aug 12, 2009·Cell Biochemistry and Biophysics·Paras K MishraSuresh C Tyagi
Dec 17, 2009·Diabetes/metabolism Research and Reviews·Biao FengSubrata Chakrabarti
Mar 31, 2010·Journal of Cardiovascular Pharmacology·Amrit Pal SinghPreet Mohinder Singh Bedi
Apr 14, 2010·Cell Biochemistry and Biophysics·Utpal SenSuresh C Tyagi
Sep 11, 2010·Cardiovascular Diabetology·Paras K MishraSuresh C Tyagi
Sep 15, 2010·Biochemical and Biophysical Research Communications·Paras Kumar MishraSuresh C Tyagi
Dec 4, 2010·Clinical Science·Madhav LavuDavid J Lefer
Sep 7, 2011·Biochemical and Biophysical Research Communications·Jun LiuYi-Chun Zhu
Jul 31, 2012·Biochemical and Biophysical Research Communications·Vishalakshi ChavaliParas K Mishra
Oct 13, 2012·Medicinal Research Reviews·Alma MartelliVincenzo Calderone
Mar 6, 2013·PloS One·Stefanos LeptidisPaula da Costa Martins
Jun 26, 2013·Cell Biochemistry and Biophysics·Vishalakshi ChavaliParas Kumar Mishra
Jan 17, 2014·Journal of Cellular and Molecular Medicine·Shali ChenSubrata Chakrabarti
Feb 12, 2014·Proceedings of the National Academy of Sciences of the United States of America·Adrienne L KingDavid J Lefer
May 9, 2014·Scandinavian Journal of Clinical and Laboratory Investigation·Paula L HedleyMichael Christiansen
Aug 19, 2014·Circulation Journal : Official Journal of the Japanese Circulation Society·Larry A Barr, John W Calvert
Nov 14, 2014·Clinical Science·Vaibhav B PatelGavin Y Oudit
Jan 13, 2015·Nutrition Journal·Paul Ganguly, Sreyoshi Fatima Alam

❮ Previous
Next ❯

Citations

Jun 19, 2018·Journal of Developmental Origins of Health and Disease·B SiddeekU Simeoni
Jun 25, 2019·British Journal of Pharmacology·Mariela CastelblancoNathalie Busso
Jan 18, 2018·Oncotarget·Xiao ChenJia Liu
Jan 24, 2016·American Journal of Physiology. Heart and Circulatory Physiology·Bryan T Hackfort, Paras K Mishra
Dec 17, 2016·Journal of Cellular Biochemistry·Avisek MajumderSuresh C Tyagi
Oct 17, 2020·American Journal of Physiology. Heart and Circulatory Physiology·Shyam S NandiKaushik P Patel
Jun 18, 2017·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Yuankun ZhaiNeetu Tyagi
Feb 21, 2019·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Maha AbdelmonemAmira A Shaheen

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiac Remodeling

Cardiac remodeling in response to a myocardial infarction is characterized by progressive ventricular dilatation, cardiac hypertrophy, fibrosis, and deterioration of cardiac performance. Discover the latest research on Cardiac Remodeling here.

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

Cardiomegaly

Cardiomegaly, known as an enlarged heart, is a multifactorial disease with different pathophysiological mechanisms. Hypertension, pregnancy, exercise-induced and idiopathic causes are some mechanisms of cardiomegaly. Discover the latest research of cardiomegaly here.